BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17308059)

  • 1. 17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell lines.
    Mitchell C; Park MA; Zhang G; Han SI; Harada H; Franklin RA; Yacoub A; Li PL; Hylemon PB; Grant S; Dent P
    Mol Cancer Ther; 2007 Feb; 6(2):618-32. PubMed ID: 17308059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95.
    Park MA; Zhang G; Mitchell C; Rahmani M; Hamed H; Hagan MP; Yacoub A; Curiel DT; Fisher PB; Grant S; Dent P
    Mol Cancer Ther; 2008 Sep; 7(9):2633-48. PubMed ID: 18790746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis.
    Qiao L; Studer E; Leach K; McKinstry R; Gupta S; Decker R; Kukreja R; Valerie K; Nagarkatti P; El Deiry W; Molkentin J; Schmidt-Ullrich R; Fisher PB; Grant S; Hylemon PB; Dent P
    Mol Biol Cell; 2001 Sep; 12(9):2629-45. PubMed ID: 11553704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species.
    Walker T; Mitchell C; Park MA; Yacoub A; Rahmani M; Häussinger D; Reinehr R; Voelkel-Johnson C; Fisher PB; Grant S; Dent P
    Mol Cancer Ther; 2010 May; 9(5):1378-95. PubMed ID: 20442308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.
    Qiao L; Han SI; Fang Y; Park JS; Gupta S; Gilfor D; Amorino G; Valerie K; Sealy L; Engelhardt JF; Grant S; Hylemon PB; Dent P
    Mol Cell Biol; 2003 May; 23(9):3052-66. PubMed ID: 12697808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes.
    Fang Y; Han SI; Mitchell C; Gupta S; Studer E; Grant S; Hylemon PB; Dent P
    Hepatology; 2004 Oct; 40(4):961-71. PubMed ID: 15382121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53.
    Qiao L; McKinstry R; Gupta S; Gilfor D; Windle JJ; Hylemon PB; Grant S; Fisher PB; Dent P
    Hepatology; 2002 Jul; 36(1):39-48. PubMed ID: 12085347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
    Park MA; Hamed HA; Mitchell C; Cruickshanks N; Dash R; Allegood J; Dmitriev IP; Tye G; Ogretmen B; Spiegel S; Yacoub A; Grant S; Curiel DT; Fisher PB; Dent P
    Mol Pharmacol; 2011 Mar; 79(3):368-80. PubMed ID: 21119025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP27 expression levels are associated with the sensitivity of hepatocellular carcinoma cells to 17-allylamino-17-demethoxygeldanamycin.
    Cui Y; Wu W; Zhou Y; Xie Q; Liu T; Jin J; Liu K
    Future Oncol; 2013 Mar; 9(3):411-8. PubMed ID: 23469976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling.
    Zhang G; Park MA; Mitchell C; Walker T; Hamed H; Studer E; Graf M; Rahmani M; Gupta S; Hylemon PB; Fisher PB; Grant S; Dent P
    J Biol Chem; 2008 Sep; 283(36):24343-58. PubMed ID: 18614532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis.
    Qiao D; Stratagouleas ED; Martinez JD
    Carcinogenesis; 2001 Jan; 22(1):35-41. PubMed ID: 11159738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation.
    Gupta S; Natarajan R; Payne SG; Studer EJ; Spiegel S; Dent P; Hylemon PB
    J Biol Chem; 2004 Feb; 279(7):5821-8. PubMed ID: 14660582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-induced stimulation of extracellular signal-regulated kinase in trout hepatocytes: the role of reactive oxygen species, Ca2+, and cell energetics and the impact of extracellular signal-regulated kinase signaling on apoptosis and necrosis.
    Nawaz M; Manzl C; Lacher V; Krumschnabel G
    Toxicol Sci; 2006 Aug; 92(2):464-75. PubMed ID: 16672322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
    Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
    Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis.
    Hostein I; Robertson D; DiStefano F; Workman P; Clarke PA
    Cancer Res; 2001 May; 61(10):4003-9. PubMed ID: 11358818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GST-MDA-7 toxicity in human glioblastoma cells by ERBB1, ERK1/2, PI3K, and JNK1-3 pathway signaling.
    Yacoub A; Gupta P; Park MA; Rhamani M; Hamed H; Hanna D; Zhang G; Sarkar D; Lebedeva IV; Emdad L; Koumenis C; Curiel DT; Grant S; Fisher PB; Dent P
    Mol Cancer Ther; 2008 Feb; 7(2):314-29. PubMed ID: 18281516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
    Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
    Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-kinase inhibitor combination recreates multipathway effects of a geldanamycin analogue on hepatocellular carcinoma cell death.
    Pritchard JR; Cosgrove BD; Hemann MT; Griffith LG; Wands JR; Lauffenburger DA
    Mol Cancer Ther; 2009 Aug; 8(8):2183-92. PubMed ID: 19671754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
    Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
    Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.